Biography

Chong H. Kim is an Associate Director at Gilead Sciences, Inc. His research interests include real-world evidence/observational research, economic modeling, clinical outcome assessment, predictive modeling, and spatial statistics. Currently, he is leading HEOR research in support of the liver & inflammation assets at Gilead.

Interests

  • HEOR
  • Observational research
  • Predictive modeling
  • Spatial statistics

Education

  • PhD in Pharmaceutical Outcomes Research, 2020

    University of Colorado, Anschutz Medical Campus

  • MS in Biostatistics, 2020

    University of Colorado, Anschutz Medical Campus

  • MPH in Health Policy & Management, 2014

    Columnbia University

Skills

R

Linux

Python

Statistics

DB analysis

Research

Experience

 
 
 
 
 

Associate Director

Gilead Sciences

May 2022 – Present California

Responsibilities include:

  • HEOR strategy & execution for pipeline, launch, and in-line assets
 
 
 
 
 

Senior Manager

Stratevi

Sep 2021 – Present California

Responsibilities include:

  • Developing proposals for generating evidence through HEOR activities
  • Executing HEOR projects (RWE generation, CEA & BIM development, Value messaging)
 
 
 
 
 

Manager

Stratevi

Jul 2020 – Sep 2021 California

Responsibilities include:

  • Supporting evidence generation efforts through HEOR activities
  • Executing HEOR projects (RWE generation, CEA & BIM development, Value messaging)
 
 
 
 
 

Associate Manager

Stratevi

Aug 2019 – Jul 2020 California

Responsibilities include:

  • Supporting projects through analysis/modeling
 
 
 
 
 

PhD Researcher

Colorado University

Aug 2015 – Jul 2019 Colorado
Conducted research to understand the impact of asthma medication use on health outcomes.

Recent Posts

Matching: Propensity & Direct

Matching with {MatchIt} Many observational studies that are published try to balance the demographic and clinical characteristics that …
Last updated on Dec 12, 2021 6 min read MatchIt

Bar chart with confidence intervals

Publication-ready bar chart with {ggplot2} I haven’t posted anything useful in a while so I decided to make a post that will hopefully …
Last updated on Nov 22, 2021 4 min read ggplot

Generating publication ready tables with {gtsummary} and {flextable}

Publication-ready tables with {gtsummary} and {flextable} So, I’ve been using R for a while now and I haven’t really found a good …
Last updated on May 4, 2021 13 min read R, gtsummary, flextable

tidymodels vs mlr3

Comparison of packages for prediction: {tidymodels} vs. {mlr3} So I wrote a lot of prediction code for my dissertation using {caret} …
Last updated on May 1, 2021 16 min read R, machine learning, mlr3, tidymodels

Sample Size Calculation with R Extended

Sample Size Caluclation in R… Extended! This is an extension from a post I saw here. When thinking about study designs for a trial that …
Last updated on Apr 29, 2021 4 min read Sample Size, Power, R
See all posts

Recent & Upcoming Talks

Recent Publications

Quickly discover relevant content by filtering publications.

Health resource utilization and costs of care for adult patients with relapsed or refractory mantle cell lymphoma in the United States: a retrospective claims analysis

ABSTRACTObjectives We assessed real-world healthcare resource utilization (HRU) and costs among US patients with relapsed or refractory …
DOI

Neighbors-based prediction of physical function after total knee arthroplasty

The purpose of this study was to develop and test personalized predictions for functional recovery after Total Knee Arthroplasty (TKA) …
Source Document

Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States

Abstract Aims To examine the impact of active only (A) vs. combined passive & active (PA) hemostatic products on bleeding-related …
David A. Iannitti, Chong H. Kim, Diane Ito, Josh Epstein
Source Document DOI

An economic analysis of different treatments for bleeding in patients with acquired haemophilia

Background Acquired haemophilia A (AHA), with potentially high risk of morbidity and mortality, occurs as a result of inhibitors …
Source Document DOI

Popular Topics

analysis barchart bleeding blogdown CAR-T cost-effectiveness analysis digital ocean error evaluation flextable ggplot gtsummary haemophilia heor hugo machine learning missing values predictive modeling R simulation

Contact